EphA2xCD3 DART antibodies (MacroGenics)

N/A

Report date: 2026/03/19 16:58:34

Base Information

Drug NameEphA2xCD3 DART antibodies (MacroGenics)
Drug Alias NameAnti-CD3/Anti-EphA2 Bispecific T-Cell Engager (MacroGenics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionEphrin type-A receptor 2 modulatorsT cell surface glycoprotein CD3 modulators
TargetsT cell surface glycoprotein CD3Ephrin type-A receptor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMacrogenics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMacrogenics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A